Dr. Harlan Robins

For the Media

Dr. Harlan Robins

Dr. Harlan Robins is a member of Fred Hutch's divisions of Public Health Sciences and Human Biology. His research is focused on the adaptive immune system adn its response to cancer and viral infection.

Resources for more information

Overview of Harlan Robins' Research Focus
Using high-throughput sequencing technology developed by Dr. Robins and his collaborators, he is working toward a comprehensive description of the t-cell repertoire and studying the dynamins of immune response.

Harlan Robins - Brief Curriculum Vitae
Appointments, affiliations and researcher interests

Herbold Computational Biology Program
Bridging a gap between experimental and computational/statistical research to address new areas of research. Researchers with core computational training bring unique perspectives to approaches to solving important biological problems.

Robins Lab
Lab members and collaborators are using mutiplex screening assays to isolate and sequence millions of T-cell receptor VDJ arrangments to create a comprehensive description of the T cell.

Public Health Sciences Division
Using large populations as their laboratory, public-health researchers look for links between cancer and its possible triggers, from diet and lifestyle to environmental and genetic factors.  


Hutch Team

For more information or to arrange an interview, please contact Fred Hutch at (206) 667-2210 or email our media relations team.



Download photos and view a video of Dr. Harlan Robins.

Related Stories

At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first National Cancer Institute-funded cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.